Asthma control and sputum eosinophils: A longitudinal study in daily practice

Sophie Demarche (Liege, Belgium), Sophie Demarche, Florence Schleich, Virginie Paulus, Monique Henket, Thierry Van Hees, Renaud Louis

Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Session: Exploring mechanisms in obstructive airway diseases
Session type: Poster Discussion
Number: 607
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sophie Demarche (Liege, Belgium), Sophie Demarche, Florence Schleich, Virginie Paulus, Monique Henket, Thierry Van Hees, Renaud Louis. Asthma control and sputum eosinophils: A longitudinal study in daily practice. Eur Respir J 2015; 46: Suppl. 59, 607

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Study of the small airway and its role in pediatric asthma control assessment
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Peripheral pathological ILC2: An inflammatory indicator for the assessment of asthma control in clinics
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016


The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015


Priorities for asthma R&D in Europe: A systematic approach
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


Tiotropium for uncontrolled asthma (a meta-analysis)
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013



Blood neutrophil pattern is associated with poor asthma control in adults from the EGEA study
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015

U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013



Value of HRCT in assessment of airway wall thickness in uncontrolled asthmatic: Five years follow-up study
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Using induced sputum cell counts to guide management of difficult-to-treat asthmatics
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013

P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016

Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016


Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Asthma and the role of blood glucose monitoring
Source: International Congress 2016 – Systemic biomarkers
Year: 2016